<p>abrdn Life Sciences Investors (NYSE:HQL - 获取免费报告) 的股票在周一创下了新的 52 周高点。该股最高交易价为$18.10，最后交易价为$18.00，成交量为 134715 股。该股此前收盘价为$18.01。</p>
<h2>abrdn Life Sciences Investors 股票表现</h2>
<p>该公司的 50 日移动平均线为$16.76，200 日移动平均线为$16.82。</p>
<h2>abrdn Life Sciences Investors 增加股息</h2>
<p>该公司最近还披露了季度股息，已于 3 月 31 日（星期二）支付。2 月 20 日（星期五）的股东记录将获得$0.56 的股息。这比 abrdn Life Sciences Investors 之前的季度股息$0.50 有所增加。除息日期为 2 月 20 日（星期五）。这代表着每年$2.24 的股息和 12.5% 的收益率。</p>
<h2>机构资金流入和流出</h2>
<p>机构投资者最近对该公司的持仓进行了调整。Shaker Financial Services LLC 在第三季度将其在 abrdn Life Sciences Investors 的股份增加了 536.8%。Shaker Financial Services LLC 现在拥有 197,804 股该公司的股票，价值$3,068,000，此前在该期间购买了额外的 166,742 股。World Investment Advisors 在第三季度购买了 abrdn Life Sciences Investors 的新股份，价值约$1,440,000。LPL Financial LLC 在第四季度将其在 abrdn Life Sciences Investors 的股份增加了 20.0%。LPL Financial LLC 现在拥有 448,846 股该公司的股票，价值$7,532,000，此前在上个季度收购了额外的 74,787 股。Wolverine Asset Management LLC 在第三季度将其在 abrdn Life Sciences Investors 的股份增加了 50.8%。Wolverine Asset Management LLC 现在拥有 215,521 股该公司的股票，价值$3,343,000，此前在上个季度收购了额外的 72,601 股。最后，Landscape Capital Management L.L.C.在第四季度购买了 abrdn Life Sciences Investors 的新股份，价值约$1,158,000。机构投资者持有该公司 32.21% 的股票。</p>
<h2>关于 abrdn Life Sciences Investors</h2>
<p>(获取免费报告)</p>
<p>abrdn Life Sciences Investors NYSE: HQL 是一家封闭式管理投资公司，旨在通过投资生命科学领域实现资本增值。该信托成立于 1994 年，专注于从事生物技术、制药、医疗设备、诊断及相关领域的公司的股票及相关证券。其封闭式结构使投资组合经理能够维持稳定的资本池，追求长期投资策略，并在适当时使用杠杆。</p>
<p>该基金的投资组合涵盖公共和私人公司，重点关注推动药物开发、基因治疗、精准医疗和医疗技术创新的企业。</p>
<h2>另请参见</h2>
<ul>
<li>五只我们更看好的股票，胜过 abrdn Life Sciences Investors</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 abrdn Life Sciences Investors 吗？</h2>
<p>在考虑 abrdn Life Sciences Investors 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 abrdn Life Sciences Investors 并不在名单上。</p>
<p>虽然 abrdn Life Sciences Investors 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

<p>abrdn Life Sciences Investors (NYSE:HQL) 达到了新的 52 周高点 18.10 美元，收盘价为 18.00 美元，交易量为 134,715 股。该公司最近将季度股息从 0.50 美元提高至 0.56 美元，收益率为 12.5%。机构投资者显著增加了其持股比例，Shaker Financial Services 的持仓增长了 536.8%。abrdn Life Sciences Investors 专注于生命科学领域的资本增值，投资于生物技术、制药和医疗技术</p>

<p>abrdn Life Sciences Investors (NYSE:HQL - Get Free Report) shares hit a new 52-week high on Monday . The stock traded as high as $18.10 and last traded at $18.00, with a volume of 134715 shares. The stock had previously closed at $18.01.</p>
<div class="lb-trans"><p>abrdn Life Sciences Investors (NYSE:HQL - 获取免费报告) 的股票在周一创下了新的 52 周高点。该股最高交易价为$18.10，最后交易价为$18.00，成交量为 134715 股。该股此前收盘价为$18.01。</p>
</div><h2>abrdn Life Sciences Investors Stock Performance</h2>
<div class="lb-trans"><h2>abrdn Life Sciences Investors 股票表现</h2>
</div><p>The company has a 50-day moving average of $16.76 and a 200 day moving average of $16.82.</p>
<div class="lb-trans"><p>该公司的 50 日移动平均线为$16.76，200 日移动平均线为$16.82。</p>
</div><h2>abrdn Life Sciences Investors Increases Dividend</h2>
<div class="lb-trans"><h2>abrdn Life Sciences Investors 增加股息</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Friday, February 20th were issued a $0.56 dividend. This is an increase from abrdn Life Sciences Investors's previous quarterly dividend of $0.50. The ex-dividend date was Friday, February 20th. This represents a $2.24 annualized dividend and a yield of 12.5%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度股息，已于 3 月 31 日（星期二）支付。2 月 20 日（星期五）的股东记录将获得$0.56 的股息。这比 abrdn Life Sciences Investors 之前的季度股息$0.50 有所增加。除息日期为 2 月 20 日（星期五）。这代表着每年$2.24 的股息和 12.5% 的收益率。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Institutional investors have recently made changes to their positions in the company. Shaker Financial Services LLC grew its stake in abrdn Life Sciences Investors by 536.8% in the third quarter. Shaker Financial Services LLC now owns 197,804 shares of the company's stock worth $3,068,000 after purchasing an additional 166,742 shares during the period. World Investment Advisors purchased a new stake in shares of abrdn Life Sciences Investors in the 3rd quarter worth about $1,440,000. LPL Financial LLC increased its stake in shares of abrdn Life Sciences Investors by 20.0% in the 4th quarter. LPL Financial LLC now owns 448,846 shares of the company's stock worth $7,532,000 after acquiring an additional 74,787 shares in the last quarter. Wolverine Asset Management LLC boosted its stake in abrdn Life Sciences Investors by 50.8% during the third quarter. Wolverine Asset Management LLC now owns 215,521 shares of the company's stock worth $3,343,000 after acquiring an additional 72,601 shares in the last quarter. Finally, Landscape Capital Management L.L.C. bought a new stake in abrdn Life Sciences Investors during the fourth quarter worth about $1,158,000. Institutional investors own 32.21% of the company's stock.</p>
<div class="lb-trans"><p>机构投资者最近对该公司的持仓进行了调整。Shaker Financial Services LLC 在第三季度将其在 abrdn Life Sciences Investors 的股份增加了 536.8%。Shaker Financial Services LLC 现在拥有 197,804 股该公司的股票，价值$3,068,000，此前在该期间购买了额外的 166,742 股。World Investment Advisors 在第三季度购买了 abrdn Life Sciences Investors 的新股份，价值约$1,440,000。LPL Financial LLC 在第四季度将其在 abrdn Life Sciences Investors 的股份增加了 20.0%。LPL Financial LLC 现在拥有 448,846 股该公司的股票，价值$7,532,000，此前在上个季度收购了额外的 74,787 股。Wolverine Asset Management LLC 在第三季度将其在 abrdn Life Sciences Investors 的股份增加了 50.8%。Wolverine Asset Management LLC 现在拥有 215,521 股该公司的股票，价值$3,343,000，此前在上个季度收购了额外的 72,601 股。最后，Landscape Capital Management L.L.C.在第四季度购买了 abrdn Life Sciences Investors 的新股份，价值约$1,158,000。机构投资者持有该公司 32.21% 的股票。</p>
</div><h2>About abrdn Life Sciences Investors</h2>
<div class="lb-trans"><h2>关于 abrdn Life Sciences Investors</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>abrdn Life Sciences Investors NYSE: HQL is a closed-end management investment company that seeks capital appreciation through investment in the life sciences sector. Established in 1994, the trust focuses on equity and equity-related securities of companies engaged in biotechnology, pharmaceuticals, medical devices, diagnostics and related fields. Its closed-end structure allows portfolio managers to maintain a stable pool of capital, pursue long-term investment strategies and employ leverage when deemed appropriate.</p>
<div class="lb-trans"><p>abrdn Life Sciences Investors NYSE: HQL 是一家封闭式管理投资公司，旨在通过投资生命科学领域实现资本增值。该信托成立于 1994 年，专注于从事生物技术、制药、医疗设备、诊断及相关领域的公司的股票及相关证券。其封闭式结构使投资组合经理能够维持稳定的资本池，追求长期投资策略，并在适当时使用杠杆。</p>
</div><p>The fund’s portfolio spans both public and private companies, with an emphasis on businesses driving innovation in drug development, gene therapy, precision medicine and healthcare technology.</p>
<div class="lb-trans"><p>该基金的投资组合涵盖公共和私人公司，重点关注推动药物开发、基因治疗、精准医疗和医疗技术创新的企业。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另请参见</h2>
</div><ul>
<li>Five stocks we like better than abrdn Life Sciences Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 abrdn Life Sciences Investors</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in abrdn Life Sciences Investors Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 abrdn Life Sciences Investors 吗？</h2>
</div><p>Before you consider abrdn Life Sciences Investors, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 abrdn Life Sciences Investors 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and abrdn Life Sciences Investors wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 abrdn Life Sciences Investors 并不在名单上。</p>
</div><p>While abrdn Life Sciences Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 abrdn Life Sciences Investors 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

abrdn Life Sciences Investors（NYSE:HQL）创下 1 年新高 - 原因如下